placebo to indacaterol maleate/mometasone furoate
Sponsors
Novartis
Conditions
Asthma
Phase 2
Bronchodilatory Efficacy of a Single Dose QMF149 (Indacaterol Maleate/Mometasone Furoate) Via the Twisthaler® Device in Adult Patients With Asthma
CompletedNCT00556673
Start: 2007-10-31End: 2008-04-30Updated: 2013-04-22
Safety and Tolerability of Indacaterol Maleate/Mometasone Furoate Delivered Via the Twisthaler® Device After 14 Days Treatment in Patients With Mild to Moderate Asthma
CompletedNCT00605306
Start: 2008-01-31End: 2008-04-30Updated: 2013-04-22